EGFR, KRAS, and PIK3CA gene mutations have a correlation with the clinical characteristics of lung cancer patients, which should be further accepted and improved to enhance the efficacy for personalized cancer treatment. The gene discussed is PIK3CA; the disease is lung cancer.